- Trials with a EudraCT protocol (367)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (5)
367 result(s) found for: Antiviral Drug.
Displaying page 1 of 19.
EudraCT Number: 2010-024479-20 | Sponsor Protocol Number: E5501-G000-203 | Start Date*: 2011-11-24 | ||||||||||||||||||||||||||
Sponsor Name:Eisai Limited | ||||||||||||||||||||||||||||
Full Title: A Phase 2, Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel-Group Study, with an Open-Label Extension to Evaluate the Efficacy, Safety, and Pharmacokinetics of E5501 in Subjects ... | ||||||||||||||||||||||||||||
Medical condition: Thrombocytopenia associated with chronic hepatitis C virus | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DE (Completed) BG (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-005863-25 | Sponsor Protocol Number: FTB-11-TFV01 | Start Date*: 2012-04-26 |
Sponsor Name:Katholieke Universiteit Leuven - Pharmacotechnology and Biopharmacy | ||
Full Title: Gastrointestinal behavior of tenofovir DF in healthy volunteers | ||
Medical condition: healthy volunteers (administration of antiviral drug) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-001469-16 | Sponsor Protocol Number: TPL102357 | Start Date*: 2005-10-20 |
Sponsor Name:GlaxoSmithKline Research and Development Limited | ||
Full Title: A double-blind, randomized, placebo-controlled, multi-centre, dose-ranging, parallel group, phase II study to assess efficacy, safety/tolerability, and pharmacokinetics of a thrombopoietin receptor... | ||
Medical condition: Thrombocytopenia caused by hepatitis-C | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) DE (Prematurely Ended) ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-004442-15 | Sponsor Protocol Number: HISTORY | Start Date*: 2013-09-11 | ||||||||||||||||
Sponsor Name:University Leipzig | ||||||||||||||||||
Full Title: High-dose intravenous silibinin infusions during 10 days as add-on treatment to triple therapy (telaprevir, peginterferon alpha and ribavirin) in cirrhotic GT 1 hepatitis C virus infected patients ... | ||||||||||||||||||
Medical condition: High-dose intravenous silibinin infusions during 10 days as add-on treatment to triple therapy (telaprevir, peginterferon alpha and ribavirin) in cirrhotic GT 1 hepatitis C virus infected patients ... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-001283-37 | Sponsor Protocol Number: GE-ARNICA-2008 | Start Date*: 2007-09-24 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA | |||||||||||||
Full Title: Chronic hepatitis C in illicit drug users and the role of antiviral therapy: the ARNICA project (Antiviral tReatment for chroNic hepatItis C in Active substance users) | |||||||||||||
Medical condition: Chronic Hepatitis C | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005393-32 | Sponsor Protocol Number: M13-101 | Start Date*: 2012-08-10 | |||||||||||
Sponsor Name:AbbVie Deutschland GmbH & Co. KG | |||||||||||||
Full Title: An Open-Label Study to Evaluate the Safety, Antiviral Activity and Pharmacokinetics of Direct-Acting Antiviral Agent (DAA) Treatment in Combination with Peginterferon α-2a and Ribavirin (pegIFN/RBV... | |||||||||||||
Medical condition: Chronic Hepatitis C infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Completed) DE (Completed) BE (Completed) HU (Completed) SE (Completed) AT (Completed) NL (Completed) IT (Completed) CZ (Prematurely Ended) IE (Completed) SK (Completed) PT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001705-26 | Sponsor Protocol Number: CYD-GER-0401 | Start Date*: 2005-09-21 |
Sponsor Name:Spirig Pharma AG | ||
Full Title: Efficacy and safety of topically applied cyclodextrin gel (Spirig Pharma) in the treatment of recurrent genital herpes simplex virus infections: a randomised, double-blind, placebo-controlled, mult... | ||
Medical condition: Genito-anal herpes simplex infections | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-005366-34 | Sponsor Protocol Number: WV43042 | Start Date*: 2021-02-12 | |||||||||||
Sponsor Name:F. Hoffmann La Roche Ltd. | |||||||||||||
Full Title: A PHASE II RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE ANTIVIRAL ACTIVITY, SAFETY, PHARMACOKINETICS, AND EFFICACY OF RO7496998 (AT-527) IN NON-HOSPITALIZED ADULT PATIENTS WI... | |||||||||||||
Medical condition: Coronavirus disease 2019 (COVID-19) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) BG (Completed) ES (Completed) LV (Completed) GR (Completed) LT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-005487-26 | Sponsor Protocol Number: AI468-038 | Start Date*: 2015-07-03 | |||||||||||
Sponsor Name:ViiV Healthcare UK Limited | |||||||||||||
Full Title: A Phase 2b Randomized, Active-Controlled, Double-Blind Trial to Investigate Safety, Efficacy and Dose-response of BMS-955176, Given on a Backbone of Tenofovir/Emtricitabine, in Treatment-Naive HIV-... | |||||||||||||
Medical condition: HIV | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) ES (Completed) GB (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022568-11 | Sponsor Protocol Number: AI452-008 | Start Date*: 2011-04-20 | |||||||||||
Sponsor Name:Bristol Myers Squibb International Corporation | |||||||||||||
Full Title: A Phase 2B, randomized study to evaluate the safety and efficacy of Pegylated Interferon Lambda (BMS-914143) administered with Ribavirin plus a single direct antiviral agent (BMS-790052 or BMS-6500... | |||||||||||||
Medical condition: Chronic Hepatitis C | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) IT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004946-17 | Sponsor Protocol Number: TPL103922 | Start Date*: 2007-11-02 | |||||||||||
Sponsor Name:GlaxoSmithKline S.A. España | |||||||||||||
Full Title: Estudio multicéntrico aleatorizado, controlado con placebo, para evaluar la eficacia y la seguridad de eltrombopag en sujetos trombocitopénicos infectados por el virus de la hepatitis C (VHC) que, ... | |||||||||||||
Medical condition: Sujetos trombocitopénicos con infección vírica por Hepatitic C. Thrombocytopenic subjects with hepatitis C viral infection. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) FR (Completed) BE (Completed) NL (Completed) IT (Completed) CZ (Completed) GB (Completed) SK (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-003640-23 | Sponsor Protocol Number: IRRB/05/18 | Start Date*: 2019-05-29 | |||||||||||||||||||||
Sponsor Name:ISTITUTO MEDITERRANEO PER I TRAPIANTI E TERAPIE AD ALTA SPECIALIZZAZIONE - ISMETT | |||||||||||||||||||||||
Full Title: USE OF HEPATITIS C+ DONORS FOR SOLID ORGAN TRANSPLANTATION IN A GEOGRAPHICAL AREA WITH HCV+ ENDEMIC INFECTION AND WITH A LOW-RATE CADAVERIC ORGAN DONOR AVAILABILITY. A PHASE II OPEN, MONOCENTRIC CL... | |||||||||||||||||||||||
Medical condition: USE OF POSITIVE DONORS FOR INFECTION OF THE HEPATITIS VIRUS FOR THE TRANSPLANTATION OF SOLID ORGANS IN AN ENDEMIC AREA FOR HEPATITIS C WITH LOW RATE OF DONATIONS FROM CADAVERS: OPEN PHASE II CLINI... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001431-30 | Sponsor Protocol Number: M05-731 | Start Date*: 2005-07-30 |
Sponsor Name:Abbott GmbH & Co. KG | ||
Full Title: A Randomized, Open Label Study Assessing Safety, Tolerability, and Efficacy of an Induction/Maintenance Treatment Strategy Including Lopinavir/ritonavir (LPV/r) plus Tenofovir Disoproxil Fumarate (... | ||
Medical condition: HIV-1 infection | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) IE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-000292-42 | Sponsor Protocol Number: TPL108390 | Start Date*: 2007-12-06 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Ltd | |||||||||||||
Full Title: ENABLE 2 (Eltrombopag to INitiate and Maintain Interferon Antiviral Treatment to Benefit Subjects with Hepatitis C related Liver DiseasE) Randomised, placebo-controlled, multi-centre study to asses... | |||||||||||||
Medical condition: Thrombocytopenic subjects with hepatitis C viral infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FR (Completed) GR (Completed) BE (Completed) ES (Completed) IT (Completed) CZ (Completed) SK (Completed) NL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-021786-78 | Sponsor Protocol Number: V1_30.4.2010 | Start Date*: 2010-11-11 | |||||||||||
Sponsor Name:Medizinische Universität Wien | |||||||||||||
Full Title: Treatment of chronic lymphocytic leukemia with the use of an antiviral compound - a proof of principle study | |||||||||||||
Medical condition: Chronic lymphocytic leukemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000660-17 | Sponsor Protocol Number: TPL108392 | Start Date*: 2009-07-29 | |||||||||||
Sponsor Name:GlaxoSmithKline | |||||||||||||
Full Title: TPL108392: An open-label, multi-centre rollover study to assess the safety and efficacy of eltrombopag in thrombocytopenic subjects with hepatitis C virus (HCV) infection who are otherwise eligibl... | |||||||||||||
Medical condition: Thrombocytopenic subjects with hepatitis C viral infection (HCV) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) DE (Completed) ES (Completed) FR (Completed) IT (Completed) GR (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002781-21 | Sponsor Protocol Number: CO11/9730 | Start Date*: 2012-02-02 |
Sponsor Name:Leeds Teaching Hospitals | ||
Full Title: A clinical study to evaluate the biological effects of administering rimantadine in patients with hepatitis C virus (HCV) infection alongside standard combination therapy with pegylated interferon ... | ||
Medical condition: Hepatitis C Virus infection - genotype 1. Genotype 1 is least responsive to current treatment and is the focus of this study. HCV can cause severe liver damage - this study will only recruit those ... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-001789-28 | Sponsor Protocol Number: IG1601 | Start Date*: 2018-04-25 | |||||||||||
Sponsor Name:Instituto Grifols S.A. | |||||||||||||
Full Title: Prevention of Mortality with Long-Term Administration of Human Albumin in Subjects with Decompensated Cirrhosis and Ascites | |||||||||||||
Medical condition: Subjects with decompensated cirrhosis and ascites | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) DE (Ongoing) FR (Ongoing) BE (Completed) GB (GB - no longer in EU/EEA) DK (Completed) IT (Ongoing) HU (Completed) BG (Ongoing) PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004698-39 | Sponsor Protocol Number: 1188.31 | Start Date*: 2006-02-03 |
Sponsor Name:Boehringer Ingelheim Pharma GmbH & Co. KG | ||
Full Title: Randomized, double-blind, placebo-controlled 7 day monotherapy Phase IIa study to evaluate the antiviral activity and safety of oral administered RTV-boosted BILR 355 (75 mg and 150 mg twice daily... | ||
Medical condition: This randomized, placebo-controlled, double-blind trial will be conducted in HIV-1 infected patients who have experienced virological failure with at least one NNRTI-based HAART regimen. The treatm... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-005709-20 | Sponsor Protocol Number: TMC435350-TiDP16-C202 | Start Date*: 2009-02-10 | |||||||||||
Sponsor Name:Tibotec Pharmaceuticals | |||||||||||||
Full Title: An open-label trial in genotype 2, 3, 4, 5 and 6 hepatitis C-infected subjects to evaluate the antiviral activity, safety, tolerability and pharmacokinetics of TMC435350 following 7 days once daily... | |||||||||||||
Medical condition: Hepatitis C virus (HCV) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.